Patent details

EP3248978 Title: DEUTERATED MORPHINAN COMPOUNDS

Basic Information

Publication number:
EP3248978
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP171797046
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DEUTERATED MORPHINAN COMPOUNDS
French Title of Invention:
COMPOSÉS DE MORPHINANE DEUTÉRÉS
German Title of Invention:
DEUTERIERTE MORPHINANVERBINDUNGEN
SPC Number:

Dates

Filing date:
18/09/2009
Grant date:
07/08/2019
EP Publication Date:
29/11/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/08/2019
EP B1 Publication Date:
07/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/09/2019
Expiration date:
18/09/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/07/2019
 
 

Name:
Concert Pharmaceuticals Inc.
Address:
99 Hayden Avenue, Suite 100, Lexington, MA 02421, United States (US)

Inventor

1

Name:
Silverman, I. Robert
Address:
United States (US)

2

Name:
Graham, Philip B.
Address:
United States (US)

Priority

Priority Number:
98511 P
Priority Date:
19/09/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/195; A61K 31/4709; A61K 31/485; A61P 25/08; A61P 25/16; A61P 29/00; C07B 59/00; C07D 471/08;

Publication

European Patent Bulletin

Issue number:
201932
Publication date:
07/08/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages